18.10
-0.10
(-0.55%)
At close: January 10 at 5:15:00 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
17,239.00
17,239.00
15,981.00
765.00
4,171.00
Investing Cash Flow
-5,177.00
-5,177.00
-1,362.00
-739.00
1,184.00
Financing Cash Flow
-3,523.00
-3,523.00
-1,834.00
-3,524.00
13,039.00
End Cash Position
36,973.00
36,973.00
28,444.00
15,694.00
19,205.00
Capital Expenditure
-5,177.00
-5,177.00
-1,362.00
-739.00
-1,092.00
Issuance of Capital Stock
521.00
521.00
3.00
40.00
18,031.00
Repayment of Debt
--
--
-294.00
-45.00
-1,361.00
Free Cash Flow
12,062.00
12,062.00
14,619.00
26.00
3,079.00
12/31/2020 - 12/14/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
POLB.L Poolbeg Pharma PLC
5.15
-8.04%
SCLP.L Scancell Holdings plc
10.10
+3.59%
FUM.L Futura Medical plc
30.38
-1.06%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
7IZ.MU Ziccum AB
0.0298
-29.72%
PH4.F CStone Pharmaceuticals
0.2640
-1.49%
ONC.L Oncimmune Holdings plc
13.40
-0.74%
41X.F Ardelyx, Inc.
5.12
+0.16%